Left Brain Wealth Management’s Pfizer PFE Stock Holding History

Left Brain Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$299K	Buy	12,417 +4,769	+62%	+$125K	0.09%	85
2026 Q1	$215K	Buy	+7,648	New	+$204K	0.08%	73

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Left Brain Wealth Management's PFE Position: Q2 2026 in Review

Left Brain Wealth Management increased its Pfizer (PFE) stake by 62% in Q2 2026, buying an estimated $125K and bringing the position to 12,417 shares worth $299K. The position accounts for 0.09% of the portfolio, ranked #85.

Left Brain Wealth Management first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Left Brain Wealth Management held 12,417 shares of Pfizer worth $299K as of Q2 2026.
Left Brain Wealth Management bought 4,769 Pfizer shares in Q2 2026, an estimated $125K.
Pfizer made up 0.09% of Left Brain Wealth Management's portfolio in Q2 2026, its #85 holding.
Left Brain Wealth Management first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Left Brain Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.